The neurological presentation of ceruloplasmin gene mutations
Alisdair McNeill1, Massimo Pandolfo, Jens Kuhn
1Department of Clinical Genetics, NIHR, Birmingham Women's Hospital, Birmingham, UK. Amcneill@doctors.org.uk
Abstract:
Aceruloplasminemia is an autosomal recessive disorder of iron metabolism resulting from mutations of the ceruloplasmin gene. To better define the neurological phenotype of aceruloplasminemia we reviewed reports of published cases and sought details of unpublished ones. We identified 32 published reports and 1 unpublished case. The age at diagnosis ranged from 16 to 71 years with a mean of 51. For the 28 homozygous cases the most common presentation was with cognitive impairment (12/28, 42%) accompanied by craniofacial dyskinesia (8/28, 28%), cerebellar ataxia (13/28, 46%) and retinal degeneration (21/28, 75%). Four heterozygotes presented with cerebellar signs or tremor, whilst 1 had chorea-athetosis. There were no genotype-phenotype associations, but homozygotes tended to have severer disease.
Insights
Aceruloplasminemia, a rare iron metabolism disorder, primarily affects the brain and eyes. This review highlights cognitive impairment, ataxia, and retinal degeneration as key neurological symptoms in affected individuals.
Area of Science:
- Neurology
- Genetics
- Metabolic Disorders
Background:
- Aceruloplasminemia is an autosomal recessive disorder caused by ceruloplasmin gene mutations.
- It involves abnormal iron metabolism with potential neurological and systemic consequences.
Purpose of the Study:
- To delineate the neurological phenotype of aceruloplasminemia.
- To analyze clinical presentations across different genotypes and disease severities.
Main Methods:
- Systematic review of published case reports.
- Inclusion of an unpublished case for comprehensive analysis.
- Analysis of patient demographics, clinical signs, and diagnosis age.
Main Results:
- Thirty-three cases (32 published, 1 unpublished) were analyzed.
- Homozygous patients frequently exhibited cognitive impairment (42%), cerebellar ataxia (46%), and retinal degeneration (75%).
- Heterozygotes showed milder neurological signs, and no genotype-phenotype correlation was found, though homozygotes had more severe disease.
Conclusions:
- Aceruloplasminemia presents with a distinct neurological phenotype, primarily affecting cognition, motor control, and vision.
- Early diagnosis and understanding the spectrum of symptoms are crucial for managing this rare iron metabolism disorder.
Related Concept Videos
Hepatic Encephalopathy
Huntington Disease l: Introduction
Neural Regulation
Multiple Sclerosis l: Introduction
Parkinson Disease ll: Pathophysiology
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...


